Home Newsfeeds Oppenheimer Downgrades 8×8 to Perform

Oppenheimer Downgrades 8×8 to Perform

Oppenheimer analyst Timothy Horan downgrades 8×8 (NYSE:EGHT) from Outperform to Perform.

byBenzinga Newsdesk

August 5, 2022

1 minute read

Oppenheimer analyst Timothy Horan downgrades 8×8 (NYSE:EGHT) from Outperform to Perform.

Why E-Commerce Company Liquidity Services Shares Are Sliding Today

By Nabaparna Bhattacharya

December 7, 12:02 PM

Liquidity Services (NASDAQ: LQDT) reported Q4 revenues of $79.96 million, missing the analyst consensus of $82.73 million.

LQDT

A Balanced Case For Nvidia: A Bullish Analyst Grows ‘More Concerned’ For The Chipmaker’s Prospects

By Anusuya Lahiri

September 2, 1:41 PM

Nvidia Corp (NASDAQ:NVDA) elaborated on U.S.’s new license requirement for exports into China and Russia, acknowledged Needham analyst Rajvindra S. Gill. Future A100…

NVDA

Teleflex Recalls Certain Arrow Peripheral Catheter System Citing Risk Of Separation, Leakage

By Vandana Singh

June 26, 2:17 PM

Teleflex Incorporated (NYSE: TFX) and its subsidiary Arrow International are recalling the ARROW Endurance Extended Dwell Peripheral Catheter System after reports of catheter separation or leakage. The FDA has identified this as a Class I recall, the most serious type of recall.

TFX

Maxeon Solar Technologies Announces Pricing And Upsize Of $157.4M Public Offering Of 7.49M Shares Of Ordinary Stock At A Price Of $28/Share

By Happy Mohamed

May 17, 8:41 AM

Maxeon Solar Technologies, Ltd. ("Maxeon") (NASDAQ:MAXN) today announced the pricing of an underwritten public offering of an aggregate of 7,490,000 ordinary shares, including 5,620,000 ordinary shares

MAXN

Oppenheimer Downgrades 8×8 to Perform

Related Posts

Why E-Commerce Company Liquidity Services Shares Are Sliding Today

A Balanced Case For Nvidia: A Bullish Analyst Grows ‘More Concerned’ For The Chipmaker’s Prospects

Teleflex Recalls Certain Arrow Peripheral Catheter System Citing Risk Of Separation, Leakage

Maxeon Solar Technologies Announces Pricing And Upsize Of $157.4M Public Offering Of 7.49M Shares Of Ordinary Stock At A Price Of $28/Share